Vaccine tech transfer hard, next six months key in Covid fight, says leading vaccine makers

On Friday, senior executives from companies such as Moderna, GSK and Bharat Biotech addressed various issues on Covid vaccines, including expanding vaccine production, technology transfer and intellectual property.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/32LvWim
via IFTTT